Intellectual Property
USA Guide 2024 : New Jersey
Band 2
Email address
[email protected]Contact number
+1 973 596 4500About
Provided by Gibbons P.C.
Gibbons Intellectual Property attorneys manage patent assertions, negotiate IP transactions, conduct due diligence, and create strategic IP portfolios – both from in-house and outside counsel perspectives. High-stakes litigation is another mainstay of the Gibbons intellectual property practice. Gibbons is unique among competitors due to the diversity and depth of our attorneys’ experience. One-third of the intellectual property attorneys who practice in the firm’s Newark and New York offices are former chief patent counsel and vice presidents for intellectual property departments in major international companies spanning the life sciences, telecommunications, medical device, and other industries throughout corporate America. Our attorneys also have diversified technical backgrounds and include:
- Electrical engineers
- Mechanical engineers
- Computer software engineers
- Process engineers
- Chemists and biochemists
- Molecular and cell biologists
- Pharmacists
This firsthand industry experience results in solutions that meet clients’ legal and business objectives. And, with no “learning curves,” we are exceptionally cost efficient in what we do.
Focus areas within our Intellectual Property Group include:
- Corporate transaction-related IP
- Intellectual property audits, evaluations, and trade secret protections
- Intellectual property litigation
- Licensing
- Online business transactions
- Patent prosecution
- Trademarks and copyrights
Chambers Review
Gibbons offers a broad range of patent and trademark experience, including litigation, transactions and IP portfolio development. The firm acts for a wide array of clients, from industries including pharmaceuticals, technology and consumer products. It demonstrates particular expertise in Hatch-Waxman litigation and is also noted for its counsel on e-discovery issues.
Work Highlights
- Gibbons represented Amgen in asserting its patents against multiple generic drug manufacturers seeking to market generic versions of Amgen’s drug product, Otezla.
Notable Practitioners
David De Lorenzi frequently litigates on behalf of pharmaceutical companies in patent infringement and Hatch-Waxman cases. He is also recommended for advice on patent strategy and the treatment of IP assets in corporate transactions.
Charles Chevalier has a diverse IP practice, frequently counseling clients on licensing and transactions as well as complex patent disputes. He has particular expertise in the life sciences industry.
Ranked Lawyers at
Gibbons P.C.
New Jersey